Rapid Diagnostic Testing for Influenza and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Rapid Diagnostic Testing for Influenza Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rapid Diagnostic Testing for Influenza Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rapid Diagnostic Testing for Influenza Overall Market Size
2.1 Global Rapid Diagnostic Testing for Influenza Market Size: 2021 VS 2028
2.2 Global Rapid Diagnostic Testing for Influenza Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rapid Diagnostic Testing for Influenza Players in Global Market
3.2 Top Global Rapid Diagnostic Testing for Influenza Companies Ranked by Revenue
3.3 Global Rapid Diagnostic Testing for Influenza Revenue by Companies
3.4 Top 3 and Top 5 Rapid Diagnostic Testing for Influenza Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rapid Diagnostic Testing for Influenza Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rapid Diagnostic Testing for Influenza Players in Global Market
3.6.1 List of Global Tier 1 Rapid Diagnostic Testing for Influenza Companies
3.6.2 List of Global Tier 2 and Tier 3 Rapid Diagnostic Testing for Influenza Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Rapid Diagnostic Testing for Influenza Market Size Markets, 2021 & 2028
4.1.2 Digital RIDTs
4.1.3 Conventional RIDT
4.2 By Type - Global Rapid Diagnostic Testing for Influenza Revenue & Forecasts
4.2.1 By Type - Global Rapid Diagnostic Testing for Influenza Revenue, 2017-2022
4.2.2 By Type - Global Rapid Diagnostic Testing for Influenza Revenue, 2023-2028
4.2.3 By Type - Global Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rapid Diagnostic Testing for Influenza Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 POCT
5.1.4 Others
5.2 By Application - Global Rapid Diagnostic Testing for Influenza Revenue & Forecasts
5.2.1 By Application - Global Rapid Diagnostic Testing for Influenza Revenue, 2017-2022
5.2.2 By Application - Global Rapid Diagnostic Testing for Influenza Revenue, 2023-2028
5.2.3 By Application - Global Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Rapid Diagnostic Testing for Influenza Market Size, 2021 & 2028
6.2 By Region - Global Rapid Diagnostic Testing for Influenza Revenue & Forecasts
6.2.1 By Region - Global Rapid Diagnostic Testing for Influenza Revenue, 2017-2022
6.2.2 By Region - Global Rapid Diagnostic Testing for Influenza Revenue, 2023-2028
6.2.3 By Region - Global Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Rapid Diagnostic Testing for Influenza Revenue, 2017-2028
6.3.2 US Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.3.3 Canada Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.3.4 Mexico Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Rapid Diagnostic Testing for Influenza Revenue, 2017-2028
6.4.2 Germany Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.4.3 France Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.4.4 U.K. Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.4.5 Italy Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.4.6 Russia Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.4.7 Nordic Countries Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.4.8 Benelux Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Rapid Diagnostic Testing for Influenza Revenue, 2017-2028
6.5.2 China Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.5.3 Japan Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.5.4 South Korea Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.5.5 Southeast Asia Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.5.6 India Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Rapid Diagnostic Testing for Influenza Revenue, 2017-2028
6.6.2 Brazil Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.6.3 Argentina Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue, 2017-2028
6.7.2 Turkey Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.7.3 Israel Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.7.4 Saudi Arabia Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
6.7.5 UAE Rapid Diagnostic Testing for Influenza Market Size, 2017-2028
7 Players Profiles
7.1 BD
7.1.1 BD Corporate Summary
7.1.2 BD Business Overview
7.1.3 BD Rapid Diagnostic Testing for Influenza Major Product Offerings
7.1.4 BD Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.1.5 BD Key News
7.2 Abbot (Alere)
7.2.1 Abbot (Alere) Corporate Summary
7.2.2 Abbot (Alere) Business Overview
7.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Major Product Offerings
7.2.4 Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.2.5 Abbot (Alere) Key News
7.3 Quidel
7.3.1 Quidel Corporate Summary
7.3.2 Quidel Business Overview
7.3.3 Quidel Rapid Diagnostic Testing for Influenza Major Product Offerings
7.3.4 Quidel Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.3.5 Quidel Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Rapid Diagnostic Testing for Influenza Major Product Offerings
7.4.4 Roche Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.4.5 Roche Key News
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Corporate Summary
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Major Product Offerings
7.5.4 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.5.5 Thermo Fisher Scientific Key News
7.6 Meridian Bioscience
7.6.1 Meridian Bioscience Corporate Summary
7.6.2 Meridian Bioscience Business Overview
7.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Major Product Offerings
7.6.4 Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.6.5 Meridian Bioscience Key News
7.7 Analytik Jena
7.7.1 Analytik Jena Corporate Summary
7.7.2 Analytik Jena Business Overview
7.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Major Product Offerings
7.7.4 Analytik Jena Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.7.5 Analytik Jena Key News
7.8 Princeton BioMeditech Corporation
7.8.1 Princeton BioMeditech Corporation Corporate Summary
7.8.2 Princeton BioMeditech Corporation Business Overview
7.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Major Product Offerings
7.8.4 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.8.5 Princeton BioMeditech Corporation Key News
7.9 BioMerieux
7.9.1 BioMerieux Corporate Summary
7.9.2 BioMerieux Business Overview
7.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Major Product Offerings
7.9.4 BioMerieux Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.9.5 BioMerieux Key News
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Corporate Summary
7.10.2 Sekisui Diagnostics Business Overview
7.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Major Product Offerings
7.10.4 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.10.5 Sekisui Diagnostics Key News
7.11 Response Biomedical
7.11.1 Response Biomedical Corporate Summary
7.11.2 Response Biomedical Business Overview
7.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Major Product Offerings
7.11.4 Response Biomedical Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.11.5 Response Biomedical Key News
7.12 SA Scientific
7.12.1 SA Scientific Corporate Summary
7.12.2 SA Scientific Business Overview
7.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Major Product Offerings
7.12.4 SA Scientific Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.12.5 SA Scientific Key News
7.13 DiaSorin (Focus Diagnostics)
7.13.1 DiaSorin (Focus Diagnostics) Corporate Summary
7.13.2 DiaSorin (Focus Diagnostics) Business Overview
7.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Major Product Offerings
7.13.4 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.13.5 DiaSorin (Focus Diagnostics) Key News
7.14 Wondfo
7.14.1 Wondfo Corporate Summary
7.14.2 Wondfo Business Overview
7.14.3 Wondfo Rapid Diagnostic Testing for Influenza Major Product Offerings
7.14.4 Wondfo Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.14.5 Wondfo Key News
7.15 Beijing Wantai Biological Pharmacy
7.15.1 Beijing Wantai Biological Pharmacy Corporate Summary
7.15.2 Beijing Wantai Biological Pharmacy Business Overview
7.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Major Product Offerings
7.15.4 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue in Global Market (2017-2022)
7.15.5 Beijing Wantai Biological Pharmacy Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Rapid Diagnostic Testing for Influenza Market Opportunities & Trends in Global Market
Table 2. Rapid Diagnostic Testing for Influenza Market Drivers in Global Market
Table 3. Rapid Diagnostic Testing for Influenza Market Restraints in Global Market
Table 4. Key Players of Rapid Diagnostic Testing for Influenza in Global Market
Table 5. Top Rapid Diagnostic Testing for Influenza Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rapid Diagnostic Testing for Influenza Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rapid Diagnostic Testing for Influenza Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rapid Diagnostic Testing for Influenza Product Type
Table 9. List of Global Tier 1 Rapid Diagnostic Testing for Influenza Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rapid Diagnostic Testing for Influenza Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rapid Diagnostic Testing for Influenza Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rapid Diagnostic Testing for Influenza Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rapid Diagnostic Testing for Influenza Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rapid Diagnostic Testing for Influenza Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2023-2028
Table 30. BD Corporate Summary
Table 31. BD Rapid Diagnostic Testing for Influenza Product Offerings
Table 32. BD Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 33. Abbot (Alere) Corporate Summary
Table 34. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Offerings
Table 35. Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 36. Quidel Corporate Summary
Table 37. Quidel Rapid Diagnostic Testing for Influenza Product Offerings
Table 38. Quidel Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Rapid Diagnostic Testing for Influenza Product Offerings
Table 41. Roche Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 42. Thermo Fisher Scientific Corporate Summary
Table 43. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Offerings
Table 44. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 45. Meridian Bioscience Corporate Summary
Table 46. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Offerings
Table 47. Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 48. Analytik Jena Corporate Summary
Table 49. Analytik Jena Rapid Diagnostic Testing for Influenza Product Offerings
Table 50. Analytik Jena Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 51. Princeton BioMeditech Corporation Corporate Summary
Table 52. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product Offerings
Table 53. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 54. BioMerieux Corporate Summary
Table 55. BioMerieux Rapid Diagnostic Testing for Influenza Product Offerings
Table 56. BioMerieux Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 57. Sekisui Diagnostics Corporate Summary
Table 58. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Offerings
Table 59. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 60. Response Biomedical Corporate Summary
Table 61. Response Biomedical Rapid Diagnostic Testing for Influenza Product Offerings
Table 62. Response Biomedical Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 63. SA Scientific Corporate Summary
Table 64. SA Scientific Rapid Diagnostic Testing for Influenza Product Offerings
Table 65. SA Scientific Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 66. DiaSorin (Focus Diagnostics) Corporate Summary
Table 67. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Offerings
Table 68. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 69. Wondfo Corporate Summary
Table 70. Wondfo Rapid Diagnostic Testing for Influenza Product Offerings
Table 71. Wondfo Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
Table 72. Beijing Wantai Biological Pharmacy Corporate Summary
Table 73. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Offerings
Table 74. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Rapid Diagnostic Testing for Influenza Segment by Type in 2021
Figure 2. Rapid Diagnostic Testing for Influenza Segment by Application in 2021
Figure 3. Global Rapid Diagnostic Testing for Influenza Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rapid Diagnostic Testing for Influenza Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rapid Diagnostic Testing for Influenza Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rapid Diagnostic Testing for Influenza Revenue in 2021
Figure 8. By Type - Global Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
Figure 12. US Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
Figure 16. Germany Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 17. France Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
Figure 24. China Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 28. India Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
Figure 30. Brazil Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue Market Share, 2017-2028
Figure 33. Turkey Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rapid Diagnostic Testing for Influenza Revenue, (US$, Mn), 2017-2028
Figure 37. BD Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Quidel Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Analytik Jena Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BioMerieux Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Response Biomedical Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. SA Scientific Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Wondfo Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
